Literature DB >> 1457260

Diethylcarbamazine in the treatment of patients with onchocerciasis.

K Awadzi1, H M Gilles.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1457260      PMCID： PMC1381407          DOI： 10.1111/j.1365-2125.1992.tb05632.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  48 in total

1.  [Attempt at a collective treatment with diethylcarbamazine in a village in the region of Bamako (Mali) where onchocerciasis is hyperendemic].

Authors:  A Rougemont; M E Boisson; G Borges da Silva; N Zander
Journal:  Bull World Health Organ       Date:  1976       Impact factor: 9.408

Review 2.  Ivermectin as an antiparasitic agent for use in humans.

Authors:  W C Campbell
Journal:  Annu Rev Microbiol       Date:  1991       Impact factor: 15.500

3.  A histological study of onchocerciasis treated with hetrazan.

Authors:  F HAWKING
Journal:  Br Med J       Date:  1952-05-10

4.  The effect of moderate urine alkalinisation on low dose diethylcarbamazine therapy in patients with onchocerciasis.

Authors:  K Awadzi; K K Adjepon-Yamoah; G Edwards; M L Orme; A M Breckenridge; H M Gilles
Journal:  Br J Clin Pharmacol       Date:  1986-06       Impact factor: 4.335

5.  Effects of high doses of diethylcarbamazine on adult Onchocerca volvulus examined by the collagenase technique and by histology.

Authors:  E J Albiez; G Walter; A Kaiser; H S Newland; A T White; B M Greene; H R Taylor; D W Büttner
Journal:  Trop Med Parasitol       Date:  1988-06

6.  Double-blind study of ivermectin and diethylcarbamazine in African onchocerciasis patients with ocular involvement.

Authors:  M Lariviere; P Vingtain; M Aziz; B Beauvais; D Weimann; F Derouin; J Ginoux; H Schulz-Key; P Gaxotte; D Basset
Journal:  Lancet       Date:  1985-07-27       Impact factor: 79.321

7.  Effects of diethylcarbamazine on ocular onchocerciasis.

Authors:  J Anderson; H Fuglsang; T F de C Marshall
Journal:  Tropenmed Parasitol       Date:  1976-09

8.  Effects of various concentrations of diethylcarbamazine citrate applied as eye drops in ocular onchocerciasis, and the possibilities of improved therapy from continuous non-pulsed delivery.

Authors:  B R Jones; J Anderson; H Fuglsang
Journal:  Br J Ophthalmol       Date:  1978-07       Impact factor: 4.638

9.  Quantification of the ocular reactions to microfilaricides in the chemotherapy of onchocerciasis.

Authors:  M Hero; A C Bird; K Awadzi
Journal:  Eye (Lond)       Date:  1992       Impact factor: 3.775

10.  Dangerous reactions to treatment of onchocerciasis with diethylcarbamazine.

Authors:  A D Bryceson; D A Warrell; H M Pope
Journal:  Br Med J       Date:  1977-03-19
View more
  11 in total

1.  Unfulfilled potential: using diethylcarbamazine-fortified salt to eliminate lymphatic filariasis.

Authors:  Patrick Lammie; Trevor Milner; Robin Houston
Journal:  Bull World Health Organ       Date:  2007-07       Impact factor: 9.408

Review 2.  Clinical pharmacokinetics in the treatment of tropical diseases. Some applications and limitations.

Authors:  G Edwards; P A Winstanley; S A Ward
Journal:  Clin Pharmacokinet       Date:  1994-08       Impact factor: 6.447

3.  Bma-LAD-2, an Intestinal Cell Adhesion Protein, as a Potential Therapeutic Target for Lymphatic Filariasis.

Authors:  Alexander F Flynn; Rebekah T Taylor; Marzena E Pazgier; Sasisekhar Bennuru; Alyssa R Lindrose; Spencer L Sterling; C Paul Morris; Brynna I Gleeson; Tim K Maugel; Thomas B Nutman; Edward Mitre
Journal:  mBio       Date:  2022-04-27       Impact factor: 7.786

4.  Clinical picture and outcome of Serious Adverse Events in the treatment of Onchocerciasis.

Authors:  Kwablah Awadzi
Journal:  Filaria J       Date:  2003-10-24

5.  Diagnosis of O. volvulus infection via skin exposure to diethylcarbamazine: clinical evaluation of a transdermal delivery technology-based patch.

Authors:  K Awadzi; Nicholas O Opoku; Simon K Attah; Janis K Lazdins-Helds; Annette C Kuesel
Journal:  Parasit Vectors       Date:  2015-10-09       Impact factor: 3.876

6.  Potential Value of Triple Drug Therapy with Ivermectin, Diethylcarbamazine, and Albendazole (IDA) to Accelerate Elimination of Lymphatic Filariasis and Onchocerciasis in Africa.

Authors:  Peter U Fischer; Christopher L King; Julie A Jacobson; Gary J Weil
Journal:  PLoS Negl Trop Dis       Date:  2017-01-05

Review 7.  Efficacy and safety of co-administered ivermectin plus albendazole for treating soil-transmitted helminths: A systematic review, meta-analysis and individual patient data analysis.

Authors:  Marta S Palmeirim; Eveline Hürlimann; Stefanie Knopp; Benjamin Speich; Vicente Belizario; Serene A Joseph; Michel Vaillant; Piero Olliaro; Jennifer Keiser
Journal:  PLoS Negl Trop Dis       Date:  2018-04-27

8.  Intestinal UDP-glucuronosyltransferase as a potential target for the treatment and prevention of lymphatic filariasis.

Authors:  Alexander F Flynn; M Gordon Joyce; Rebekah T Taylor; Sasisekhar Bennuru; Alyssa R Lindrose; Spencer L Sterling; C Paul Morris; Thomas B Nutman; Edward Mitre
Journal:  PLoS Negl Trop Dis       Date:  2019-09-12

9.  A randomized, single-ascending-dose, ivermectin-controlled, double-blind study of moxidectin in Onchocerca volvulus infection.

Authors:  Kwablah Awadzi; Nicholas O Opoku; Simon K Attah; Janis Lazdins-Helds; Annette C Kuesel
Journal:  PLoS Negl Trop Dis       Date:  2014-06-26

Review 10.  Research for new drugs for elimination of onchocerciasis in Africa.

Authors:  Annette C Kuesel
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2016-05-19       Impact factor: 4.077
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.